Endocrine Insider
December 10, 2009

(See full Issue)

To support the goals outlined in the Society’s Scientific Statement and position statement on endocrine-disrupting chemicals, the Society endorsed the “Endocrine Disruption Prevention Act of 2009” (HR 4190/S 2828), introduced by Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) on December 3, 2009.  Entirely in line with the Society’s positions, the bill will advance endocrine science in the field of endocrine-disrupting chemicals (EDCs) and improve the regulatory process by ensuring it is informed by the best science.  Specifically, the bill addresses the need for more research on EDCs and coordinated output of research results, proposing to develop a research program under the auspices of the National Institute of Environmental Health Sciences (NIEHS).

To advance the Society’s goal of strengthening regulation of EDCs, the Society has discussed the findings of the statements with staff of the committees that have jurisdiction over this issue, including the House Energy and Commerce Committee and the Senate Environment and Public Works Committee, and with the staff of Representatives Moran, Slaughter (D-NY), Rush (D-IL), and Markey (D-MA) .  The Society also provided comments on draft language to overhaul the Toxic Substance Control Act and will continue to offer support to this process in the coming months.  As reported in a previous edition of Endocrine Insider, the American Medical Association (AMA) also supported a Society-sponsored resolution calling for improved regulation of EDCs.